Ligand validation:6BW6

TUM: Tunicamycin

TUM is a Ligand Of Interest in 6BW6 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BW6_TUM_A_501	42%	23%	0.208	0.929	1.67	1.49	13	11	1	0	100%	1
6BW6_TUM_D_501	40%	21%	0.226	0.94	1.67	1.65	14	14	0	0	100%	1
6BW6_TUM_C_501	40%	23%	0.228	0.94	1.67	1.54	14	14	0	0	100%	1
6BW6_TUM_B_502	31%	23%	0.254	0.926	1.68	1.52	14	13	0	0	100%	1
6BW5_TUM_A_501	42%	22%	0.212	0.933	1.71	1.54	13	17	1	0	100%	1
5JNQ_TUM_A_401	46%	53%	0.129	0.902	0.59	1.23	-	8	0	0	79%	0.7895

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.